Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 2 Results

Intervention Indication Therapeutic Area Year Actions
Erdafitinib capsules for metastatic or surgically unresectable urothelial cancer with FGFR gene aberrations – second line therapy Erdafitinib (JNJ-42756493; BALVERSA) Urothelial cancer Urological Cancer 2017 View  |  Download
Erdafitinib for treating advanced solid tumours with an FGFR mutation in people aged 6 years and older Erdafitinib (JNJ-42756493; BALVERSA) Solid tumours Haematological Cancer and Lymphomas , Oncology 2021 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications